12:00 AM
 | 
Nov 16, 2015
 |  BC Week In Review  |  Company News  |  Other News

Biodel endocrine/metabolic news

Biodel will reduce headcount by 10 (30%) to about 23 and restructure research and quality-related activities to focus on later-stage clinical development programs. The company expects the restructuring...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >